Subcellular fractionation of dystrophin to the triads of skeletal muscle

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Nature

• Publication date

  1987-12-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/330754A0PMID 2447503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention

  2004cited by this paper
• Calcium-sensitive non-muscle alpha-actinin contains EF-hand structures and highly conserved regions.

  1987cited by this paper
• Protein sequence of DMD gene is related to actin-binding domain of alpha-actinin.

  1987cited by this paper
• Primary structure of the receptor for calcium channel blockers from skeletal muscle

  1987cited by this paper
• A cDNA clone from the Duchenne/Becker muscular dystrophy gene

  1987cited by this paper
• Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor.

  1987cited by this paper
• Is Nebulin the Product of Duchenne Muscular Dystrophy Gene?

  1987cited by this paper
• Identification and characterization of the high affinity [3H]ryanodine receptor of the junctional sarcoplasmic reticulum Ca2+ release channel.

  1987cited by this paper
• Conservation of the Duchenne muscular dystrophy gene in mice and humans.

  1987cited by this paper
• Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2+-permeable pore of the calcium release channel.

  1987cited by this paper
• Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

  1987cited by this paper
• Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene

  1986cited by this paper
• Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels

  1985cited by this paper
• Experimental skeletal muscle damage: the nature of the calcium‐activated degenerative processes

  1984cited by this paper
• Purification of morphologically intact triad structures from skeletal muscle

  1983cited by this paper
• Production of large amounts of antibodies, nonspecific immunoglobulins, and other serum proteins in ascitic fluids of individual mice and guinea pigs.

  1983cited by this paper
• The structure of the T-system in human muscular dystrophy. A high-voltage electron-microscopic study.

  1982cited by this paper
• Normal function in sarcoplasmic reticulum from mice with muscular dystrophy

  1982cited by this paper
• The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease.

  1982cited by this paper
• Further characterization of light and heavy sarcoplasmic reticulum vesicles. Identification of the 'sarcoplasmic reticulum feet' associated with heavy sarcoplasmic reticulum vesicles.

  1980cited by this paper
• The amino acid sequence of rabbit skeletal alpha-tropomyosin. The NH2-terminal half and complete sequence.

  1978cited by this paper
• A simplification of the protein assay method of Lowry et al. which is more generally applicable.

  1977cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Disorders of voluntary muscle

  1969cited by this paper

• Pilot study of canakinumab (Ilaris) in steroid naïve children with Duchenne muscular dystrophy demonstrates safety and exploratory changes in potential serum protein response biomarkers

  2025cites this paper
• The Importance of Early Diagnosis and Treatment to Limit the Impact of Dystrophic Cardiomyopathy—We’ve Seen This Film Before, and We Didn’t Like the Ending

  2025cites this paper
• Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle

  2025cites this paper
• Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy

  2024cites this paper
• Adenylosuccinic Acid: An Orphan Drug with Untapped Potential

  2023cites this paper
• Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models

  2023cites this paper
• Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1

  2023influential citation
• An overview of recent US-approved gene therapies for Duchenne muscular dystrophy and their respective clinical development programs

  2023cites this paper
• Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.( Dissertation_全文 )

  2022cites this paper
• Beneficial impacts of neuromuscular electrical stimulation on muscle structure and function in the zebrafish model of Duchenne muscular dystrophy

  2022cites this paper
• Neuromuscular disease: Gene transfer for children: What we know now

  2022cites this paper
• CALCIUM ADENOSINE 5’ TRIPHOSPHATASE ENZYME ACTIVITY IN EXTRAOCULAR MUSCLES IN STRABISMUS

  2021cites this paper
• Mechanics of dystrophin deficient skeletal muscles in very young mice and effects of age.

  2021cites this paper
• Induced Fetal Human Muscle Stem Cells with High Therapeutic Potential in a Mouse Muscular Dystrophy Model

  2020cites this paper
• Analysis of duplications versus deletions in the dystrophin gene in Serbian cohort with dystrophinopathies

  2020cites this paper
• CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review

  2019cites this paper
• Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases

  2019cites this paper
• Update in Duchenne and Becker muscular dystrophy.

  2019cites this paper
• Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy

  2019cites this paper
• Skipping Multiple Exons to Treat DMD—Promises and Challenges

  2018cites this paper
• Effects of chronic hypoxia on diaphragm function in deer mice native to high altitude

  2018cites this paper
• Integrative effects of dystrophin loss on metabolic function of the mdx mouse

  2018cites this paper
• Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury

  2017cites this paper
• Development Aspects of Zebrafish Myotendinous Junction: a Model System for Understanding Muscle Basement Membrane Formation and Failure

  2017cites this paper
• Mass spectrometric identification of dystrophin, the protein product of the Duchenne muscular dystrophy gene, in distinct muscle surface membranes

  2017cites this paper
• Investigating the brain in mouse models of Duchenne muscular dystrophy

  2017cites this paper
• Duchenne Muscular Dystrophy and Becker Muscular Dystrophy Confirmed by Multiplex Ligation-Dependent Probe Amplification: Genotype-Phenotype Correlation in a Large Cohort

  2016cites this paper
• Mechanosensory Transduction: Focus on Ion Channels

  2016cites this paper
• Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice

  2016cites this paper
• [Modeling muscular diseases by patient-derived iPS cells].

  2016cites this paper
• Evolving natural history in Duchenne muscular dystrophy : implications for standard of care and experimental therapies

  2016cites this paper
• 2015 William Allan Award.

  2016cites this paper
• Therapeutic Approach of iPS Cell Technology for Treating Muscular Dystrophy

  2016cites this paper
• Engineering and optimisation of mini-dystrophin constructs for Duchenne muscular dystrophy gene therapy

  2015influential citation
• Satellite cells from dystrophic muscle retain regenerative capacity

  2015cites this paper
• Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy

  2015cites this paper
• Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.

  2015cites this paper
• BMP4 inhibits myogenic differentiation of bone marrow-derived mesenchymal stromal cells in mdx mice.

  2015cites this paper
• The Pathogenesis and Therapy of Muscular Dystrophies.

  2015cites this paper
• The role of acute ambient hypoxia in the regulation of myostatin

  2015cites this paper
• Design and application of RNA therapeutics for splice site mutations

  2015cites this paper
• Costamere proteins and their involvement in myopathic processes

  2015cites this paper
• Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells

  2015cites this paper
• Therapeutic effects of exon skipping and losartan on skeletal muscle of mdx mice

  2014cites this paper
• Description of a utrophin associated protein complex in lipid raft domains of human artery smooth muscle cells.

  2014cites this paper
• Lamina-associated polypeptide 1: protein interactions and tissue-selective functions.

  2014cites this paper
• ASHG AWARDS AND ADDRESSES

  2014cites this paper
• STUDIES ON LINEAGE SHIFT RESPONSES OF HUMAN PERIPHERAL BLOOD MULTIPOTENT CELLS

  2014cites this paper
• Sodium dysregulation coupled with calcium entry leads to muscular dystrophy in mice

  2014cites this paper
• Transfection efficiency in rat soleus and SERCA1b expression in human skeletal muscles

  2014cites this paper
• Isolation of primary myoblasts and characterization of the endoplasmic reticulum stress response in wild-type and mdx mice

  2014cites this paper
• Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy

  2014cites this paper
• Finding the Sweet Spot: Assembly and Glycosylation of the Dystrophin‐Associated Glycoprotein Complex

  2014influential citation
• Dystrophin and Its Associated Glycoprotein Complex

  2013cites this paper
• Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance.

  2013cites this paper
• Dmdmdx/Largemyd: a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies

  2013cites this paper
• Muscle fibre types: their role in health, disease and as therapeutic targets

  2013cites this paper
• The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy

  2013cites this paper
• Subcellular localization and mechanism of secretion of vascular endothelial growth factor in human skeletal muscle

  2013cites this paper
• Concise Review: Stem Cell Therapy for Muscular Dystrophies

  2012cites this paper
• 6.5 Mechanosensory Transduction

  2012cites this paper
• Aorta-derived mesoangioblasts for cell therapy of cardiomyopathy in Duchenne Muscular Dystrophy

  2012cites this paper
• CREB Is Activated by Muscle Injury and Promotes Muscle Regeneration

  2011cites this paper
• 19 – Treatment and Management of Muscular Dystrophies

  2011cites this paper
• Dystrophinopathies.

  2011cites this paper
• Quantificação da força muscular e habilidades motoras de pacientes com Distrofia Muscular de Duchenne, em corticoterapia por período de 1 a 7 anos

  2010cites this paper
• AAV-directed muscular dystrophy gene therapy

  2010cites this paper
• RNA-targeted splice-correction therapy for neuromuscular disease.

  2010cites this paper
• Un adenovirus exprimant MyoD induit la myogenèse des cellules souches embryonnaires humaines

  2009cites this paper
• Diagnostic utility of skin biopsy in dystrophinopathies.

  2009cites this paper
• Cytoskeletal tropomyosin Tm5NM1 is required for normal excitation-contraction coupling in skeletal muscle.

  2009cites this paper
• Distribution of β‐dystroglycan immunopositive globules in the subventricular zone of rat brain

  2009cites this paper
• Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice.

  2008cites this paper
• L-Type Ca2+ Channel Function Is Linked to Dystrophin Expression in Mammalian Muscle

  2008cites this paper
• Gene map of mental retardation.

  2008cites this paper
• Twenty-one years later: Twenty-first century rehabilitation

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) Duchenne and Becker muscular dystrophy . Neurological , cardiological and genetic studies in carriers and patients

  2007cites this paper
• Medical genetics--genes and GPs for the 1990s.

  2007cites this paper
• [Site specific mutagenesis by homologous recombination in embryonic stem cells].

  2006cites this paper
• Greater Susceptibility of the Sarcoplasmic Reticulum to H2O2 Injuries in Diaphragm Muscle from mdx Mice

  2006influential citation
• Mutagenèse dirigée par recombinaison homologue dans les cellules es

  2006cites this paper
• Inherited Disorders of the Neuromuscular Junction

  2006cites this paper
• The effects of glucocorticoid therapy on the inflammatory and Dendritic cells in muscular dystrophies

  2006cites this paper
• Cloning of the DMD Gene

  2005cites this paper
• Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx mouse muscle fibres

  2005cites this paper
• Chronic exercise accelerates the degeneration–regeneration cycle and downregulates insulin‐like growth factor‐1 in muscle of mdx mice

  2005cites this paper
• Kapitel 57 – Progressive Muskeldystrophien, Myotonien, periodische Paralysen, distale und kongenitale Myopathien

  2005cites this paper
• 2004 William Allan Award address. Cloning of the DMD gene.

  2005cites this paper
• Mini‐dystrophin restores L‐type calcium currents in skeletal muscle of transgenic mdx mice

  2004cites this paper
• The action potential‐evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres

  2004cites this paper
• Difference in the expression pattern of dystrophin on the surface membrane between the skeletal and cardiac muscles of mdx carrier mice

  2004cites this paper
• The expression of α-dystrobrevin and dystrophin during skeletal muscle regeneration

  2004cites this paper
• The expression of dystrophin and α1-syntrophin during skeletal muscle regeneration

  2004cites this paper
• Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury.

  2004cites this paper
• Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse

  2004cites this paper
• Developmental expression of dystrophin on the rat myocardial cell membrane

  2004cites this paper
• Muscle hypertrophy in Duchenne muscular dystrophy

  2004cites this paper
• PROTEINS OF MUSCLE SUBCELLULAR FRACTIONS IN DUCHENNE PROGRESSIVE MUSCULAR DYSTROPHY CATIONIC CARBOCYANINE DYE AND W I T H COOMASSIE BLUE STAINED WITH “STAINS=ALL”

  2004cites this paper
• Loss of intracellular dystrophin: a potential mechanism for myocardial reperfusion injury.

  2003cites this paper
• The expression of dystrophin, alpha-sarcoglycan, and beta-dystroglycan during skeletal muscle regeneration: immunohistochemical and western blot studies.

  2002cites this paper